CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis

• DOI: 10.1002/alr.23002
• Publication Date: 2022-04-01T17:49:17Z
• Authors: Samuel D. Racette; Alexander L. Schn...; Meera Ganesh; Julia H. Huang; David S. Lehmann; Caroline P.E. Price; Samuel G. Rodegherio; Abhita T. Reddy; Jacob G. Eide; David B. Conley; Kevin C. Welch; Robert C. Kern; Stephanie Shintan...; Atsushi Kato; Robert P. Schleimer; Bruce K. Tan
• Keywords: Nasal Polyps; Chronic Rhinosinusitis; Endoscopic sinus surgery

The 22-item Sino-Nasal Outcome Test (SNOT-22) and 12-item Patient Reported Outcomes in Chronic Rhinosinusitis (CRS-PRO) instrument are validated patient-reported outcomes measures CRS. In this study we assess the correlation of these with type 2 (T2) biomarkers before after endoscopic sinus surgery (ESS).